2006
DOI: 10.1016/j.regpep.2006.04.011
|View full text |Cite
|
Sign up to set email alerts
|

Anti-edematogenic effects of velutinol A isolated from Mandevilla velutina: Evidence for a selective inhibition of kinin B1 receptor-mediated responses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 32 publications
0
5
0
Order By: Relevance
“…To confirm the involvement of the B 1 receptor in DSS‐induced colitis, animals were i.p. treated with DALBK (a peptide selective B 1 receptor antagonist) (Campos et al ., ; McLean et al ., ; Calixto et al ., ; Brunius et al ., ; Leeb‐Lundberg et al ., ; Hamza et al ., ) and SSR240612 (a non‐peptide selective B 1 receptor antagonist) (Gougat et al ., ; Campos et al ., ; Mattos et al ., ). Surprisingly, pretreatment with either DALBK (50 nmol·kg −1 , i.p., twice a day) or SSR240612 (10 mg·kg −1 , p.o., twice a day) were not capable of preventing colitis, and even worsened the DAI (Figure A) and body weight loss (Figure B) following the administration of DSS.…”
Section: Resultsmentioning
confidence: 97%
“…To confirm the involvement of the B 1 receptor in DSS‐induced colitis, animals were i.p. treated with DALBK (a peptide selective B 1 receptor antagonist) (Campos et al ., ; McLean et al ., ; Calixto et al ., ; Brunius et al ., ; Leeb‐Lundberg et al ., ; Hamza et al ., ) and SSR240612 (a non‐peptide selective B 1 receptor antagonist) (Gougat et al ., ; Campos et al ., ; Mattos et al ., ). Surprisingly, pretreatment with either DALBK (50 nmol·kg −1 , i.p., twice a day) or SSR240612 (10 mg·kg −1 , p.o., twice a day) were not capable of preventing colitis, and even worsened the DAI (Figure A) and body weight loss (Figure B) following the administration of DSS.…”
Section: Resultsmentioning
confidence: 97%
“…All results when positive showed a statistical difference between them and the three antibacterial agents and a reference antifungal agent using the Tukey's test with (P < 0.05). According to Sampaio et al (2021), the Mandevilla genus has several pharmacological applications as venom inhibition, anti-edematogenic and anti-inflammatory activity (BIONDO et al, 2003;MATTOS et al, 2006;ALMEIDA et al, 2017). Thus, it is important to highlight the main biological and pharmacological properties described in the literature was antibacterial and bacteriostatic activity like flavonoids, organic acids, tannins, triterpenoids, phenols, and alkaloids (DUARTE et al, 2014;BARCELOS et al, 2017;CARVALHO et al, 2020;SANTOS et al, 2020).…”
Section: Results and Discussisonmentioning
confidence: 99%
“…Phytochemical investigation have shown that triterpenoids isolated from the Maytenus species exhibit potent inhibitory effects on prostaglandin E 2 (PGE 2 ) production in mice macrophages stimulated with a bacterial endotoxin (Reyes et al, 2006). Mattos et al (2006) observed the anti-edematogenic effects of a steroid isolated from plants that was effective in reducing the edematogenic responses evoked by carrageenan. Moreover, flavonoids play an important role in various biological processes, such as antihepatotoxic, antiallergic, anti-inflammatory, antiosteoporotic and antitumor activities (Di Carlo et al, 1999).…”
Section: Discussionmentioning
confidence: 99%